Expand MTNB Menu
MTNB MENU

Matinas Biopharma Hldgs (MTNB) closed at $1.70 on October 23, 2026, down 0.5% from the previous close, on volume of 11,101 shares (30-day average 364,545).

Key numbers
  • Last close: $1.70 (October 23, 2026)
  • 52-week range: $0.15 to $3.15
  • Market value: $25.0 million

Data as of October 23, 2026.

MTNB Stock Summary and Trading Ideas (Matinas Biopharma Hldgs | AMEX:MTNB)

Charts for Today's Stock Price and Implied Volatility in Matinas Biopharma Hldgs

23-Oct-2026

Stock Price & Volume | Full Chart

Sentiment

Trading Statistics

Key Ratios

Matinas Biopharma Hldgs (MTNB) Frequently Asked Questions

What does Matinas Biopharma Hldgs do?

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

What symbol and exchange does Matinas Biopharma Hldgs shares trade?

Matinas Biopharma Hldgs trades on the AMEX stock market under the symbol MTNB.

What is Matinas Biopharma Hldgs stock price doing today?

As of October 23, 2026, MTNB stock price declined to $1.70 with 11,101 million shares trading.

What is Matinas Biopharma Hldgs's Beta?

MTNB has a beta of 1.13, meaning it tends to be more sensitive to market movements. MTNB has a correlation of 0.00 to the broad based SPY ETF.

How much is Matinas Biopharma Hldgs worth?

MTNB has a market cap of $24.99 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Matinas Biopharma Hldgs traded in the last 3 year period?

In the last 3 years, MTNB traded as high as $4.49 and as low as $.09.

What are the top ETFs holding Matinas Biopharma Hldgs?

The top ETF exchange traded funds that MTNB belongs to (by Net Assets): VXF.

Is Matinas Biopharma Hldgs (MTNB) a good investment?

MTNB has underperformed the market in the last year with a price return of +7.6% while the SPY ETF gained +14.3%. However, in the short term, MTNB had mixed performance relative to the market. It has outperformed in the last 3 months, returning +582.4% vs +3.2% return in SPY. But in the last 2 weeks, MTNB shares have been beat by the market, returning -40.7% compared to an SPY return of -2.4%.

What are the support and resistance levels for Matinas Biopharma Hldgs (MTNB)?

MTNB support price is $1.54 and resistance is $1.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MTNB shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes